Clinical Trial Update: Equivalence Study of Dorzolamide 2% Eye Drops Solution [Phase 3]

View source ↗

Summary

Phase 3 equivalence study evaluating dorzolamide 2% eye drops has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Dorzolamide (Dorzolamide)

Snippet

Sponsor: Alfred E. Tiefenbacher (GmbH & Co. KG) | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED